Latest stories
-
Talazoparib and Enzalutamide Combination Moves Earlier in Prostate Cancer Treatment
Talazoparib, marketed under the brand name Talzenna, is a significant medication in the fight against cancer, specifically breast and prostate cancer. As…
-
Formula E Gen3 Car Offers 200 mph, 350 kW Power and 600 kW Regenerative Braking
London, October 4 — The shift is clear: Formula E’s Gen3 race cars are pushing electric vehicle technology further than ever before,…
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
LONDON, July 15 — The shift is stark: a new study from the Indiana University School of Medicine suggests bowel cancer patients…
-
Altman and Musk Back Amodei’s Call to Pace AI Development as Trump Pushes Back
San Francisco, September 18 — The fight over how fast artificial intelligence should move has turned inward, and the industry is splitting…
-
Smartwatches Overestimate Calories Burned, and Errors Grow With Body Fat, Florida Study Finds
COPENHAGEN, May 23 — The smartwatch on your wrist is probably lying to you about how many calories you just burned, and…
-
Israel Opens Tenders for 1,234 E1 Settlement Homes in West Bank as Allies Condemn Move
West Bank Expansion Sparks Global Alarms as Israel Moves Forward Jerusalem, August 21 — Israel’s decision to open tenders for new settlement…
-
Germany Investigates Suspected Russian Weapons Cache Found in Woods Near Berlin
Berlin, August 21 — The discovery of a Russian-linked gun stash in a forest near Berlin last year has sent ripples through…
-
Ukraine Says Nearly 3,000 Africans Recruited Into Russia’s Army, 486 of Them Dead
On August 21, Moscow — the recruitment of nearly 3,000 Africans into Russia’s armed forces has ignited fresh concerns about both military…
-
Multi-cancer blood tests show early promise, but doctors want proof they work
ROME, July 16 — The shift is happening in plain sight. Cancer detection is moving from single-organ biopsies to a single blood…
-
Akeso starts US Phase II cadonilimab trial in gastric cancer with Memorial Sloan Kettering
ISLAMABAD, July 15 — Akeso, the Chinese biopharmaceutical company, has advanced its investigational drug cadonilimab into a Phase II clinical trial in…
-
Sir John Hardy, Geneticist Behind Landmark Alzheimer’s Research, Honored with Top Science Prizes
LONDON, July 14 — The shift is this: one man’s hypothesis, now over three decades old, still drives the most promising treatments…
-
Ukraine War Shook Global Food and Energy Markets in 2022 and 2023
LONDON, July 11 — The shift is unmistakable. Two years after the Black Sea Grain Initiative ended, the aftershocks of Russia’s invasion…
-
CAR-T Still Stalls on Solid Tumors, but Two New Targeting Ideas Are Gaining Ground
Six CAR T‑cell products have earned FDA approval, but each is limited to hematologic malignancies such as multiple myeloma, B‑cell leukemias and…
-
Cash Now Makes Up 46% of Payments Worldwide, but Is Unlikely to Disappear Soon
STOCKHOLM, July 8 — The shift away from physical cash is no longer a future prediction; it is a documented, accelerating trend…
-
Computer Study Links Tyre Chemical 6PPD-Quinone to Genes Tied to Alzheimer’s Disease
WASHINGTON — A chemical found in a tire preservative may be interfering with the inner workings of brain cells, raising early questions…
-
Ancient Immune Protein Made Inside Tumors Boosts Cancer Immunotherapy in Nagoya Study
“You can’t just rip out a receptor that does useful work everywhere in the body,” said Erick M. Carreira, co-leader of the…
-
Minor’ £60 mistake ‘could cost you your home
LONDON, July 4 — The shift is small and easy to dismiss: a £60 parking fine you refuse to pay on principle.…
-
New Infrastructure Planning Guidance Mandates Health Impact Assessments
The government’s new national infrastructure planning guidance runs through a set of numbers that define how major projects in England will get…
-
Father’s Hope Shattered as Rare Brain Cancer Returns
SOUTH SHIELDS, July 2 — A first-time father has been told he has up to 12 months to live after a routine…
-
Muscle cells found to release anti-cancer signals, study reveals
SINGAPORE — A new study from Duke-NUS Medical School suggests that aging muscle does not simply lose strength — it may also…
-
The Malaga doctor leading pioneering cancer treatment for children
MALAGA, June 30 — The shift in childhood cancer treatment is happening inside a Madrid lab, led by a researcher from the…
-
Germany’s Record Heat Brings Calls for Air Conditioning in Care Homes and Hospitals
BERLIN — The asphalt cracked. Trains stopped. And inside nursing homes and hospitals across Germany, residents and patients sweltered in rooms without…
-
Diabetic man falls into coma as Siberian ambulance has no fuel amid Russian shortages
A diabetic man slipped into a coma. His wife called for an ambulance. The dispatcher told her to find her own ride.…
-
WHO reports 1,300 excess deaths in Europe amid record heatwave
Forty degrees Celsius in Germany, the Czech Republic and Poland. That was Sunday. One thousand three hundred excess deaths across Europe since…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992